Evidence map›Paper›PMID 40783608›Full record

ArticleScientific reports2025

Risk factors for prolonged hospitalization in acute decompensated heart failure from the HEROES study.

Mateusz Lucki, Przemysław Mitkowski, Ewa Lucka, Marek Grygier, Ewa Straburzyńska-Migaj, Robert Morawiec, Agnieszka Kapłon-Cieślicka, Agata Galas, Katarzyna Byczkowska, Piotr Hamala and 11 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Mateusz Lucki1st Department of Cardiology, Chair of Cardiology, Poznan University of Medical Sciences, Poznan, Poland. mateusz.lucki@ump.edu.pl.
Przemysław Mitkowski1st Department of Cardiology, Chair of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Ewa LuckaClinical Rehabilitation Laboratory, Department of Rehabilitation and Physiotherapy, Poznan University of Medical Sciences, Poznan, Poland. ewachlebus@ump.edu.pl.
Marek Grygier1st Department of Cardiology, Chair of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Ewa Straburzyńska-Migaj1st Department of Cardiology, Chair of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Robert Morawiec2nd Department of Cardiology, Medical University of Lodz, Lodz, Poland.
Agnieszka Kapłon-CieślickaFirst Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Agata GalasDepartment of Cardiology and Internal Diseases, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
Katarzyna ByczkowskaNational Institute of Cardiology, Warsaw, Poland.
Piotr Hamala1st Department and Chair of Cardiology, Medical University of Lodz, Lodz, Poland.
Iwona Gorczyca-GłowackaCollegium Medicum, The Jan Kochanowski University, Kielce, Poland.
Anna Furman-NiedziejkoSaint John Paul II Hospital, Krakow, Poland.
Dominika Klimczak-TomaniakDepartment of Cardiology, Hypertension and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
Agnieszka Major1st Clinic of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Center, Kielce, Poland.
Adrian StefańskiDepartment of Hypertension and Diabetology, Faculty of Medicine, Medical University of Gdansk, Gdańsk, Poland.
Mateusz GuzikInstitute of Heart Diseases, Wroclaw Medical University, Wrocław, Poland.
Małgorzata ZachuraCollegium Medicum, The Jan Kochanowski University, Kielce, Poland.
Mateusz StaciwaDepartment of Internal Diseases and Clinical Pharmacology, Medical University of Lodz, Lodz, Poland.
Ewa PierzchałaClinical Cardiology at PIM MSWiA Hospital, Wrocław, Poland.
Maciej Nadel2nd Department of Cardiology, Medical University of Lodz, Lodz, Poland.
Maciej Lesiak1st Department of Cardiology, Chair of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study, part of the HEROES project (HEart failure Risk factOrs and patiEnt Stratification), aimed to identify clinical, laboratory, functional, and treatment-related factors associated with hospitalization duration (above and below 8 days) in patients admitted for acute decompensated heart failure (ADHF). We analyzed 562 Caucasian patients hospitalized due to acute decompensated heart failure (ADHF), divided into two groups based on length of stay (LOS): ≤ 8 days (n = 287; 51.07%) and > 8 days (n = 275; 48.93%). In the ≤ 8 days group, 203 patients (70.73%) were male, while in the > 8 days group, 202 patients (73.45%) were male. Data on sociodemographic features, clinical characteristics, laboratory and imaging findings, treatment details, and patient-reported health status (KCCQ-12) were collected. Multivariate logistic regression identified independent predictors of prolonged hospitalization. Patients with longer LOS had higher NYHA class (p < 0.001), greater comorbidity burden (p = 0.0019), longer intensive cardiac care unit (ICCU) stay (p < 0.001), and higher in-hospital mortality (p = 0.0006). They also showed elevated NT-proBNP (p < 0.0001), procalcitonin (p = 0.03), and creatinine (p = 0.0002), and lower hemoglobin (p = 0.004), hematocrit (p = 0.014), and sodium (p = 0.0325). In the multivariate analysis, independent predictors of prolonged hospitalization included treatment with norepinephrine (OR = 18.41), dopamine (OR = 8.62), and oral iron therapy (OR = 3.25). Conversely, protective factors associated with a reduced risk of prolonged hospitalization were higher KCCQ-12 scores (OR = 0.98), higher systolic blood pressure at admission (OR = 0.99), and prior statin use (OR = 0.56). In the HEROES study, prolonged hospitalization among ADHF patients was associated with more severe symptoms of heart failure decompensation higher comorbidity load, impaired functional and laboratory parameters and need for longer stay in ICCU. Early identification of high-risk patients may facilitate personalized management and optimize healthcare resource utilization.

Indexed as

Heart FailureHospitalizationLength of StayAcute DiseaseAgedAged, 80 and overFemaleHospital MortalityHumansMaleMiddle AgedNatriuretic Peptide, BrainRisk FactorsNatriuretic Peptide, BrainHeart failureHospitalizationLength of stayPrognostic indicatorsRisk factors

Identifiers

PMID40783608
PMCPMC12335576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.